Tokyo Tape
Sign in
← ASKA Pharmaceutical Holdings

Half-year report · HY

4886.TEDINET S100WZ8Y
Period2025-04-01 → 2025-09-30
Filed2025-11-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥35.3bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥64.1bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥32.4bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥2.6bn2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥3.3bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥2.7bn2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥5.1bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.3bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥2.8bn2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥3.3bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥2.2bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.1bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.6bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥2.4bn2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥2.6bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥108.8bnat 2025-09-30Cons.Assets
Total assets¥103.9bnat 2025-03-31Cons.Assets
Total assets¥88.3bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥36.2bnat 2025-09-30Cons.Liabilities
Total liabilities¥32.3bnat 2025-03-31Cons.Liabilities
Net assets / equity¥72.6bnat 2025-09-30Cons.Net assets
Net assets / equity¥71.6bnat 2025-03-31Cons.Net assets
Net assets / equity¥64.2bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥6.6bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥10.6bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥7.1bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥10.6bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥13.7bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥16.7bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow¥1.1bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.5bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥6.0bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥6.1bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥1.4bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥3.0bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥78.492025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥179.952024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.362024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio61.5%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio62.9%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio72.7%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-04-01 → 2025-09-30¥141m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-04-01 → 2025-09-30¥99m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-04-01 → 2025-09-30¥42m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-04-01 → 2025-09-30−¥15m
Reconciling Itemsreconcilingrevenue2025-04-01 → 2025-09-30−¥42m
Reconciling Itemsreconcilingrevenue intersegment2025-04-01 → 2025-09-30−¥42m
Reconciling Itemsreconcilingsegment profit2025-04-01 → 2025-09-30−¥870m
Animal Health Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥3.8bn
Animal Health Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥3.8bn
Animal Health Businessreportable segmentsegment profit2025-04-01 → 2025-09-30¥282m
Oversea Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥2.1bn
Oversea Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥2.1bn
Oversea Businessreportable segmentsegment profit2025-04-01 → 2025-09-30¥132m
Pharmaceutical Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥29.3bn
Pharmaceutical Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥29.3bn
Pharmaceutical Businessreportable segmentsegment profit2025-04-01 → 2025-09-30¥3.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2025-04-01 → 2025-09-30¥35.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-04-01 → 2025-09-30¥35.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2025-04-01 → 2025-09-30¥42m
Total Of Reportable Segments And Otherssegment totalsegment profit2025-04-01 → 2025-09-30¥3.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥151m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥113m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2024-09-30¥38m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30−¥4m
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥38m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥38m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥652m
Animal Health Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥3.6bn
Animal Health Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥3.6bn
Animal Health Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥177m
Pharmaceutical Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥28.6bn
Pharmaceutical Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥28.6bn
Pharmaceutical Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥3.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥32.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥32.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥38m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥4.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 488
ItemContextValueUnit
Other noeInterimDuration85000000JPY
Non operating expensesPrior1InterimDuration238000000JPY
Non operating expensesInterimDuration360000000JPY
Ordinary incomePrior1InterimDuration3312000000JPY
Ordinary incomeInterimDuration2660000000JPY
Gain on sales of property plant and equipment eiPrior1InterimDuration－JPY
Gain on sales of property plant and equipment eiInterimDuration96000000JPY
Extraordinary incomePrior1InterimDuration－JPY
Extraordinary incomeInterimDuration96000000JPY
Income before income taxesPrior1InterimDuration3312000000JPY
Income before income taxesInterimDuration2756000000JPY
Income taxes currentPrior1InterimDuration602000000JPY
Income taxes currentInterimDuration753000000JPY
Income taxes deferredPrior1InterimDuration150000000JPY
Income taxes deferredInterimDuration-378000000JPY
Income taxesPrior1InterimDuration752000000JPY
Income taxesInterimDuration374000000JPY
Profit lossPrior1InterimDuration2560000000JPY
Profit lossInterimDuration2382000000JPY
Profit loss attributable to non controlling interestsPrior1InterimDuration－JPY
Profit loss attributable to non controlling interestsInterimDuration155000000JPY
Profit loss attributable to owners of parentPrior1InterimDuration2560000000JPY
Profit loss attributable to owners of parentInterimDuration2226000000JPY
Profit lossPrior1InterimDuration2560000000JPY
Profit lossInterimDuration2382000000JPY
Valuation difference on available for sale securities net of tax ociPrior1InterimDuration-115000000JPY
Valuation difference on available for sale securities net of tax ociInterimDuration839000000JPY
Foreign currency translation adjustment net of tax ociPrior1InterimDuration－JPY
Foreign currency translation adjustment net of tax ociInterimDuration-1361000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1InterimDuration-32000000JPY
Remeasurements of defined benefit plans net of tax ociInterimDuration-27000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1InterimDuration333000000JPY
Share of other comprehensive income of associates accounted for using equity method ociInterimDuration2000000JPY
Other comprehensive incomePrior1InterimDuration185000000JPY
Other comprehensive incomeInterimDuration-546000000JPY
Comprehensive incomePrior1InterimDuration2745000000JPY
Comprehensive incomeInterimDuration1835000000JPY
Comprehensive income attributable to owners of the parentPrior1InterimDuration2745000000JPY
Comprehensive income attributable to owners of the parentInterimDuration2320000000JPY
Comprehensive income attributable to non controlling interestsPrior1InterimDuration－JPY
Comprehensive income attributable to non controlling interestsInterimDuration-484000000JPY
Income before income taxesPrior1InterimDuration3312000000JPY
Income before income taxesInterimDuration2756000000JPY
Depreciation and amortization ope cfPrior1InterimDuration1069000000JPY
Depreciation and amortization ope cfInterimDuration1355000000JPY
Amortization of goodwill ope cfPrior1InterimDuration－JPY
Amortization of goodwill ope cfInterimDuration83000000JPY
Increase decrease in retirement benefit asset and liability ope cfPrior1InterimDuration80000000JPY
Increase decrease in retirement benefit asset and liability ope cfInterimDuration57000000JPY
Interest and dividends income ope cfPrior1InterimDuration-149000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass rounding
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass